Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

Medicare's GLP-1 bridge program launches July 1 with a $50 monthly copay after major insurers rejected the original BALANCE ...

Eli Lilly (LLY) stock and Novo Nordisk (NONOF) stock are in focus as Medicare extends interim coverage for GLP-1 weight loss ...

The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from ...

Two of the biggest insurance providers have expressed reluctance to participate in the government’s BALANCE program that ...

Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for ...

Health insurers are raising questions about the Trump administration’s plan to cover obesity drugs in Medicare next year, casting doubt on whether enough insurers will sign on to the effort for it to ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

The Trump administration is indefinitely delaying a Medicare pilot program to cover weight-loss drugs after health insurance ...

The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting instead to pay for the medicine with taxpayer dollars through the ...

Retailers race into GLP-1 market as Amazon and Walmart expand weight management programs, reshaping access and care delivery in obesity treatment.

Add Yahoo as a preferred source to see more of our stories on Google. CMS has extended its GLP-1 Bridge programme The Centers ...